WebJun 30, 2024 · Hence, clinically relevant drug-drug interactions are unlikely when apremilast is co-administered with drugs that are substrates or inhibitors of these transporters. … WebOtezla is a brand-name medication manufactured by Amgen Inc. It is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, and oral ulcers associated with Behcet’s disease. While Otezla is generally well tolerated, there are some potential side effects that people should be aware of.
OTEZLA Drug Patent Profile
WebFind information on Apremilast (Otezla) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. ... Pharm. Class. phosphodiesterase type 4 inhibitors. Indications. Active psoriatic arthritis. Webclass (SOC) and frequency for all adverse reactions. Within each SOC and frequency grouping, adverse reactions are presented in order of decreasing seriousness. The … how to create a generic array
Bristol Myers Squibb - Bristol Myers Squibb’s Applications for ...
WebOtezla (Apremilast) Otezla (apremilast) is a medication used to used to treat psoriasis and the joint pain and tenderness of psoriatic arthritis. Otezla works by inhibiting an enzyme called phosphodiesterase-4 (PDE4) that is involved in the body's inflammatory response. Otezla belongs to a class of drugs known as phosphodiesterase-4 inhibitors.. Taking Otezla WebApremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis.It may also be useful for … WebSMC No. 1053/15. Apremilast (Otezla®) alone or in combination with disease modifying anti-rheumatic drugs (DMARDs), for the treatment of active psoriatic arthritis (PsA) in … how to create a gdrive folder